Barrx Medical Inc. signed an exclusive distribution deal with Medico’s Hirata for its Halo gastrointestinal disease treatment system.
Osaka, Japan-based Medico’s Hirata, a medical product supplier, said it is well-positioned to make the Halo device the standard of care in Japan.
The Halo system uses radiofrequency ablation to treat pre-cancerous lesions of the esophagus and other chronic gastrointestinal diseases, according to a Barrx press release.
Japan has one of the highest concentrations of esophageal squamous cell cancers in the world, according to the Sunnyvale, Calif.-based developer of gastroenterological endoscopic devices.
"We are excited to partner with Medico’s Hirata in one of our most important markets worldwide. … We look forward to a long mutually beneficial business relationship," Barrx CEO Greg Barrett said in prepared remarks.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.